|
51
|
DELISTED
TCR2 Therapeutics Inc. Common Stock
|
62
|
-19
|
-23%
|
$21M
|
|
|
52
|
|
60
|
+6
|
+11%
|
$183M
|
|
|
53
|
|
60
|
-7
|
-10%
|
$4.72M
|
|
|
54
|
DELISTED
NKGen Biotech, Inc. Common Stock
|
60
|
+7
|
+13%
|
$159M
|
|
|
55
|
DELISTED
Adverum Biotechnologies
|
58
|
-20
|
-26%
|
$33.1M
|
|
|
56
|
DELISTED
Gamida Cell Ltd. Ordinary Shares
|
55
|
-7
|
-11%
|
$29.1M
|
|
|
57
|
DELISTED
Athenex, Inc. Common Stock
|
53
|
-19
|
-26%
|
$6.01M
|
|
|
58
|
|
52
|
-2
|
-4%
|
$43.8M
|
|
|
59
|
DELISTED
Athersys, Inc. Common Stock
|
49
|
+5
|
+11%
|
$2.76M
|
|
|
60
|
|
49
|
-15
|
-23%
|
$18M
|
|
|
61
|
DELISTED
Orchard Therapeutics plc American Depositary Shares
|
48
|
+1
|
+2%
|
$16.5M
|
|
|
62
|
|
47
|
+2
|
+4%
|
$5.24M
|
|
|
63
|
DELISTED
CERo Therapeutics
|
45
|
-20
|
-31%
|
$101M
|
|
|
64
|
|
44
|
-8
|
-15%
|
$8.66M
|
|
|
65
|
DELISTED
BRAINSTORM CELL THERAPUTC
|
43
|
+1
|
+2%
|
$6.16M
|
|
|
66
|
|
42
|
+5
|
+14%
|
$7.89M
|
|
|
67
|
DELISTED
Rubius Therapeutics, Inc
|
42
|
-20
|
-32%
|
$11.2M
|
|
|
68
|
|
40
|
+16
|
+67%
|
$28.5M
|
|
|
69
|
|
39
|
-10
|
-20%
|
$18.3M
|
|
|
70
|
DELISTED
Decibel Therapeutics, Inc. Common Stock
|
39
|
-1
|
-3%
|
$36.2M
|
|
|
71
|
DELISTED
Sio Gene Therapies Inc. Common Stock
|
37
|
-3
|
-8%
|
$8.96M
|
|
|
72
|
|
36
|
-6
|
-14%
|
$3.73M
|
|
|
73
|
|
35
|
+1
|
+3%
|
$104M
|
|
|
74
|
DELISTED
SQZ Biotechnologies Company
|
35
|
-13
|
-27%
|
$9.35M
|
|
|
75
|
|
34
|
+1
|
+3%
|
$10.3M
|
|